Last reviewed · How we verify
Ultiva
Ultiva is a Small molecule drug developed by Seoul National University Hospital. It is currently FDA-approved. Also known as: brand-named drug of remifentanil, Ultiva™, Remifentanil.
Remifentanil, marketed under the brand name Ultiva, is a potent, short-acting synthetic opioid analgesic drug used to relieve pain during surgery and as an adjunct to an anesthetic. Ultiva is also used for sedation and in combination with other medications for general anesthesia.
At a glance
| Generic name | Ultiva |
|---|---|
| Also known as | brand-named drug of remifentanil, Ultiva™, Remifentanil |
| Sponsor | Seoul National University Hospital |
| Modality | Small molecule |
| Therapeutic area | Other |
| Phase | FDA-approved |
Approved indications
Boxed warnings
- WARNING: SERIOUS AND LIFE-THREATENING RISKS FROM USE OF ULTIVA Addiction, Abuse, and Misuse Because the use of ULTIVA exposes patients and other users to the risks of opioid addiction, abuse, and misuse, which can lead to overdose and death, assess each patient’s risk prior to prescribing and reassess all patients regularly for the development of these behaviors and conditions [see Warnings and Precautions (5.1) ] . Life-Threatening Respiratory Depression Serious, life-threatening, or fatal resp
Common side effects
- Nausea
- Vomiting
- Hypotension
- Muscle rigidity
- Bradycardia
- Shivering
- Fever
- Respiratory depression
- Dizziness
- Visual disturbance
- Headache
- Pruritus
Serious adverse events
- Respiratory depression
- Bradycardia
- Hypotension
- Muscle rigidity
- Apnea
- Chest wall rigidity
- Hypoxia
Key clinical trials
- The Relationship Between Opioid-Free Anesthesia and Postoperative Agitation-Delirium and Quality of Recovery in Pediatric Ear, Nose, and Throat Cases Monitored With Perioperative Bispectral Index
- Hemodynamic Effects of Remimazolam vs Propofol During Robot-assisted Gynecologic Surgery (NA)
- Effects of Different Drugs for Glottic Atomization on Postoperative Sore Throat After Thyroid Surgery (PHASE4)
- Comparison of Target-Controlled and Manual Total Intravenous Anesthesia in Supratentorial Surgery (NA)
- Opioid Free and Opioid Based Anesthesia in Elective Lumbar Spine Surgery
- Effect of Titrated Administration of Ciprofol on Perioperative Hypotension in Elderly Patients Undergoing Laparoscopic Abdominal Surgery: A Randomized Controlled Trial (NA)
- Awareness Neuraxial Versus General Anesthesia in Frail Patients Undergoing Laparoscopic or Robotic Abdominopelvic Surgery. (NA)
- Anesthesia Maintenance With Target-controlled Infusion of Propofol and Remifentanil at Fixed Ratio (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Ultiva CI brief — competitive landscape report
- Ultiva updates RSS · CI watch RSS
- Seoul National University Hospital portfolio CI
Frequently asked questions about Ultiva
What is Ultiva?
Who makes Ultiva?
Is Ultiva also known as anything else?
What development phase is Ultiva in?
What are the side effects of Ultiva?
Related
- Manufacturer: Seoul National University Hospital — full pipeline
- Therapeutic area: All drugs in Other
- Also known as: brand-named drug of remifentanil, Ultiva™, Remifentanil
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing